The letter highlights the strong scientific evidence supporting the safety and effectiveness of vaccines and underscores the role of the Vaccine Injury Compensation Program (VICP) in providing no-fault compensation for rare vaccine-related injuries. It emphasizes maintaining rigorous evidentiary standards and established processes for determining covered injuries, warning that adding a large number of conditions without sufficient scientific support could overwhelm the program, delay valid claims, and jeopardize its ability to function effectively and sustain access to vaccines.
To The Administration
Group letter to HHS urging the Sustainability of the Vaccine Injury Compensation Program (VICP)
- Topics: Access, Innovation
Related Letters & Comments
HLC drives policy change through strategic letters, comments, and reports that promote private-sector innovation. Focused on priorities like Medicare reform, telehealth, and health equity, HLC engages with lawmakers and agencies to shape a smarter, more responsive healthcare system.
To The Administration
Group letter to HHS urging the Sustainability of the Vaccine Injury Compensation Program (VICP)
The letter highlights the strong scientific evidence supporting the safety and effectiveness of vaccines and underscores the role of the Vaccine Injury Compensation Program (VICP) in providing no-fault compensation for rare vaccine-related injuries.…
To The Administration
Group Letter to the Administration Urging Federal Action to Address AI-Enabled Cyber Risk
HLC joined a group of trade associations recommending federal actions to address AI‑driven cybersecurity risk, including stronger public‑private coordination, workforce readiness for an AI‑enabled economy, regulatory clarity, reauthorization of the …
To Congress
Group letter to House W&M Committee urging passage of H.R. 2213, the Medical Supply Chain Resiliency Act
A broad coalition of healthcare organizations urged Congress to advance the H.R. 2213, the Medical Supply Chain Resiliency Act, bipartisan legislation to strengthen and diversify the U.S. medical supply chain by promoting domestic manufacturing and…
